Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3135)
All Articles published online
|
Jan 21, 2005 (publication date) through Apr 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kang QZ, Duan GC, Fan QT, Xi YL. Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli. World J Gastroenterol 2005; 11(3): 454-456 [PMID: 15637768 DOI: 10.3748/wjg.v11.i3.454] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i3/454.htm |
| Number | Citing Articles |
| 1 |
Chibing Gong, Yan Li, Ming Li, Jun Luo, Hong Cao, Min Long. B-cell Epitope Mapping of Helicobacter pylori Neutrophil-Activating Protein. 2007 Frontiers in the Convergence of Bioscience and Information Technologies 2007; : 261 doi: 10.1109/FBIT.2007.28
|
| 2 |
Kuo-Shun Shih, Chih-Chang Lin, Hsiao-Fang Hung, Yu-Chi Yang, Chung-An Wang, Kee-Ching Jeng, Hua-Wen Fu, William R. Abrams. One-Step Chromatographic Purification of Helicobacter pylori Neutrophil-Activating Protein Expressed in Bacillus subtilis. PLoS ONE 2013; 8(4): e60786 doi: 10.1371/journal.pone.0060786
|
| 3 |
Ashraf Mohabati Mobarez, Neda Soleimani, Seyed-Alireza Esmaeili, Baharak Farhangi. Nanoparticle-based immunotherapy of breast cancer using recombinant Helicobacter pylori proteins. European Journal of Pharmaceutics and Biopharmaceutics 2020; 155: 69 doi: 10.1016/j.ejpb.2020.08.013
|
| 4 |
FANG FANG, JICHUN MA, WEIHUA NI, FENGLI WANG, XIAXIA SUN, YINGYING LI, QIONGSHU LI, FEI XIE, JUAN WANG, RUIPING ZHAI, ZHONGHUI LIU, SUNJUN GAO, GUIXIANG TAI. MUC1 and maltose-binding protein recombinant fusion protein combined with Bacillus Calmette-Guerin induces MUC1-specific and nonspecific anti-tumor immunity in mice. Molecular Medicine Reports 2014; 10(2): 1056 doi: 10.3892/mmr.2014.2306
|
| 5 |
Xiaoyan Peng, Rongguang Zhang, Chen Wang, Feiyan Yu, Mingyang Yu, Shuaiyin Chen, Qingtang Fan, Yuanlin Xi, Guangcai Duan. E. coli Enterotoxin LtB Enhances Vaccine-Induced Anti-H. pylori Protection by Promoting Leukocyte Migration into Gastric Mucus via Inflammatory Lesions. Cells 2019; 8(9): 982 doi: 10.3390/cells8090982
|
| 6 |
Hongyue Zhou, Zenan Zhang, Guomu Liu, Mengyu Jiang, Jingjing Wang, Yu Liu, Guixiang Tai. The Effect of Different Immunization Cycles of a Recombinant Mucin1-Maltose-Binding Protein Vaccine on T Cell Responses to B16-MUC1 Melanoma in Mice. International Journal of Molecular Sciences 2020; 21(16): 5810 doi: 10.3390/ijms21165810
|
| 7 |
Fang Wang, Weihua Ni, Guomu Liu, Juan Wang, Fei Xie, Hongyan Yuan, Yingying Guo, RuiPing Zhai, Tanxiu Chen, Qiongshu Li, Guixiang Tai. Escherichia coli maltose-binding protein (MBP) directly induces mouse Th1 activation through upregulating TLR2 and downregulating TLR4 expressions. Immunobiology 2015; 220(6): 782 doi: 10.1016/j.imbio.2014.12.016
|
| 8 |
Stefan Fernandez, Dupeh R. Palmer, Monika Simmons, Peifang Sun, John Bisbing, Sasha McClain, Sachin Mani, Timothy Burgess, Vicky Gunther, Wellington Sun.
Potential Role for Toll-Like Receptor 4 in Mediating
Escherichia coli
Maltose-Binding Protein Activation of Dendritic Cells
. Infection and Immunity 2007; 75(3): 1359 doi: 10.1128/IAI.00486-06
|
| 9 |
Ting Wang, Xilong Liu, Zhenyu Ji, Yingli Men, Mingxuan Du, Cong Ding, Yahong Wu, Xin Liu, Qiaozhen Kang. Antitumor and immunomodulatory effects of recombinant fusion protein rMBP-NAP through TLR-2 dependent mechanism in tumor bearing mice. International Immunopharmacology 2015; 29(2): 876 doi: 10.1016/j.intimp.2015.08.027
|
| 10 |
Xiaoyan Peng, Rongguang Zhang, Guangcai Duan, Chen Wang, Nan Sun, Linghan Zhang, Shuaiyin Chen, Qingtang Fan, Yuanlin Xi. Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-24879-x
|
| 11 |
Min Long, Jun Luo, Yan Li, Fang-Yin Zeng, Ming Li. Detection and evaluation of antibodies against neutrophil-activating protein of <italic>Helicobacter pylori</italic> in patients with gastric cancer. World Journal of Gastroenterology 2009; 15(19): 2381-2388 doi: 10.3748/wjg.15.2381
|
| 12 |
Cong Ding, Li Li, Yi Zhang, Zhenyu Ji, Chenglong Zhang, Taotao Liang, Xun Guo, Xin Liu, Qiaozhen Kang. Toll‑like receptor agonist rMBP‑NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.9182
|
| 13 |
Dominique Velin, Pierre Michetti. The Biology of Gastric Cancers. 2009; : 601 doi: 10.1007/978-0-387-69182-4_24
|
| 14 |
Jing Jie, Yixin Zhang, Hongyue Zhou, Xiaoyu Zhai, Nannan Zhang, Hongyan Yuan, Weihua Ni, Guixiang Tai. CpG ODN1826 as a Promising Mucin1-Maltose-Binding Protein Vaccine Adjuvant Induced DC Maturation and Enhanced Antitumor Immunity. International Journal of Molecular Sciences 2018; 19(3): 920 doi: 10.3390/ijms19030920
|
| 15 |
Yuan Du, Tomomi Hashizume, Tomoko Kurita-Ochiai, Satoshi Yuzawa, Yoshimitsu Abiko, Masafumi Yamamoto. A Fusion Protein of the Hemagglutinin A Antigenic Region of Porphyromonas gingivalis and Maltose-Binding Protein Induces Antibody Responses in the Oral Cavity. International Journal of Oral-Medical Sciences 2011; 9(3): 182 doi: 10.5466/ijoms.9.182
|
| 16 |
Amin Talebi Bezmin Abadi, Yeong Yeh Lee. Chinese <i>Helicobacter pylori</i> vaccine: Solution for an old challenge?. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(3): 412-415 doi: 10.4292/wjgpt.v7.i3.412
|
| 17 |
Qingyong Zhang, Weihua Ni, Xiaoxia Zhao, Fengli Wang, Zhuo Gao, Guixiang Tai. Synergistic antitumor effects of Escherichia coli maltose binding protein and Bacillus Calmette–Guerin in a mouse lung carcinoma model. Immunology Letters 2011; 136(1): 108 doi: 10.1016/j.imlet.2010.12.005
|
| 18 |
Weihua Ni, Qingyong Zhang, Guomu Liu, Fang Wang, Hongyan Yuan, Yingying Guo, Xu Zhang, Fei Xie, Qiongshu Li, Guixiang Tai. Escherichia coli maltose-binding protein activates mouse peritoneal macrophages and induces M1 polarization via TLR2/4 in vivo and in vitro. International Immunopharmacology 2014; 21(1): 171 doi: 10.1016/j.intimp.2014.04.025
|
| 19 |
Jike Lu, Qi Song, Zhenyu Ji, Xin Liu, Ting Wang, Qiaozhen Kang. Fermentation optimization of maltose-binding protein fused to neutrophil-activating protein from Escherichia coli TB1. Electronic Journal of Biotechnology 2015; 18(4): 281 doi: 10.1016/j.ejbt.2015.05.002
|
| 20 |
Dominique Velin, Pierre Michetti. Advances in vaccination againstHelicobacter pylori. Expert Review of Gastroenterology & Hepatology 2010; 4(2): 157 doi: 10.1586/egh.10.6
|
| 21 |
Ting Wang, Mingxuan Du, Zhenyu Ji, Cong Ding, Chengbo Wang, Yingli Men, Shimeng Liu, Taotao Liang, Xin Liu, Qiaozhen Kang. Recombinant protein rMBP-NAP restricts tumor progression by triggering antitumor immunity in mouse metastatic lung cancer. Canadian Journal of Physiology and Pharmacology 2018; 96(2): 113 doi: 10.1139/cjpp-2017-0186
|
| 22 |
Abulimiti Moming, Shen Shi, Shu Shen, Jie Qiao, Xihong Yue, Bo Wang, Juntao Ding, Zhihong Hu, Fei Deng, Yujiang Zhang, Surong Sun, Paulo Lee Ho. Fine mapping epitope on Glycoprotein-Gn from Severe Fever with Thrombocytopenia Syndrome Virus. PLOS ONE 2021; 16(3): e0248005 doi: 10.1371/journal.pone.0248005
|
| 23 |
Wan Wang, Hong-Yan Yuan, Guo-Mu Liu, Wei-Hua Ni, Fang Wang, Gui-Xiang Tai. Escherichia coli Maltose-Binding Protein Induces M1 Polarity of RAW264.7 Macrophage Cells via a TLR2- and TLR4-Dependent Manner. International Journal of Molecular Sciences 2015; 16(12): 9896 doi: 10.3390/ijms16059896
|
| 24 |
Jiaojiao Liu, Cong Ding, Xiaolong Wang, Lu Yang, Xin Liu, Qiaozhen Kang. TLR agonist rMBP-NAP inhibits B16 melanoma tumor growth via induction of DCs maturation and T-cells cytotoxic response. Cytotechnology 2022; 74(4): 459 doi: 10.1007/s10616-022-00532-4
|